Melanoma Cell Line Authentication and Culture
Corresponding Organization :
Other organizations : Centre Léon Bérard, Inserm, Centre National de la Recherche Scientifique, Université Claude Bernard Lyon 1, Centre de Recherche en Cancérologie de Lyon, Hospices Civils de Lyon
Variable analysis
- Concentration of TNFα (100 ng/mL)
- Concentration of TGFβ (20 ng/mL)
- Concentration of BRAF inhibitor PLX4032/vemurafenib
- Genetic alterations in cell lines (verified by NGS sequencing)
- Mycoplasma contamination status (verified every 3 weeks)
- Cell culture medium (DMEM complemented with 10% FBS and 100 U/ml penicillin-streptomycin for A375 cells, RPMI complemented with 10% FBS and 100 U/ml penicillin-streptomycin for GLO and C-09.10 cells)
- Replacement of TNFα and TGFβ in the culture medium every 3 days
- Previously described patient-derived short-term cultures (GLO and C-09.10) established from BRAF^V600 metastatic melanomas
- Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!